Tag: Cancer: Leukemia
FDA Approves Kinase Inhibitor for Treatment of AML
                    Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults                
            Psoriasis May Up Risk of Melanoma, Hematologic Cancer
                    No differences in risk observed for type of psoriasis therapy, including systemic or biologic medications                
            Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
                    Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group                
            Blinatumomab Linked to Longer Survival in Adults With ALL
                    Significantly longer overall, event-free survival for relapsed, refractory B-cell precursor ALL                
            Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants
                    Modified T cells from healthy donor allowed infants to reach remission, researchers report                
            Personalized Vaccine Effective Against Acute Myeloid Leukemia
                    Made by combining immune cells, cancer cells, it's kept some patients in remission for nearly five years                
            American Society of Hematology, Dec. 3-6
                    
The 58th American Society of Hematology Annual Meeting & Exposition  The annual meeting of the American Society of Hematology was held from Dec....                
            Increased Cost of CLL Tx Poses Considerable Financial Burden
                    Number of patients living with CLL projected to increase 55% by 2025; costs set to rise 590%                
            Immunotherapy Promising for Tx of Acute Myeloid Leukemia
                    In preliminary trial, four of nine patients with acute myeloid leukemia had complete remission                
            Adding Rituximab to Chemo Ups Event-Free Survival in ALL
                    Findings in young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia                
            
                
		










